Multifocal High-Grade Pancreatic Precursor Lesions: A Case Series and Management Recommendations by Soufi, Mazhar et al.
CASE REPORT Open Access
Multifocal High-Grade Pancreatic Precursor Lesions:
A Case Series and Management Recommendations
Mazhar Souﬁ,1,2 Michele T. Yip-Schneider,1–3 Rosalie A. Carr,1,2 Alexandra M. Roch,1,2
Howard H. Wu,4 and Christian Max Schmidt1–3,5,6,*
Abstract
Background: The risk of developing invasive cancer in the remnant pancreas after resection of multifocal high-
grade pancreatic precursor lesions is not well known.We report three patients whowere followed up after resection
of multifocal high-grade pancreatic intraepithelial neoplasia (PanIN)-3 or intraductal papillary mucinous neoplasia
(IPMN), two of whom eventually developed invasive carcinoma.
Presentation: 1) 68-year-old woman who had a laparoscopic distal pancreatectomy for multifocal mixed-type
IPMN, identiﬁed as high-grade on ﬁnal pathology, with negative surgical margins. During semiannual monitoring,
eight years from the ﬁrst surgery, the patient developed suspicious features prompting surgical resection of the
body with ﬁnal pathology revealing invasive ductal adenocarcinoma in the setting of IPMN. 2) 48-year-old
woman who had a distal pancreatectomy for severe acute/chronic symptomatic pancreatitis, with ﬁnal pathol-
ogy revealing multifocal high-grade PanIN-3, with negative surgical margins. Despite semiannual monitoring,
two years from the ﬁrst surgery, the patient developed pancreatic adenocarcinoma with liver metastasis. 3)
55-year-old woman who had a Whipple procedure for symptomatic chronic pancreatitis, with multifocal
PanIN-3 on ﬁnal pathology. The patient underwent completion pancreatectomy due to symptomatology and
her high-risk proﬁle, with ﬁnal pathology conﬁrming multifocal PanIN-3.
Conclusion: Multifocal high-grade dysplastic lesions of the pancreas might beneﬁt from surgical resection.
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Introduction
Pancreatic cancer develops from precursor lesions. It is
theorized that such lesions progress in a step-wise man-
ner from low grade to high grade to invasive adenocar-
cinoma. Pancreatic intraepithelial neoplasia (PanIN) and
intraductal papillary mucinous neoplasia (IPMN) are
two types of precursor lesions. Although identical at
the microscopic level, they differ is size, genetics, and de-
tectability with better imaging.
The risk of recurrence after resection of IPMN is
generally considered to be low. Approximately 20%
of patients will develop recurrence in the pancreatic
remnant with a mean follow-up of 66 months.1 Some
studies have focused on the risk of high grade or inva-
sive IPMN recurrence after resection of a unifocal high-
grade dysplastic lesion,1,2 but to our knowledge, there
have been no published reports investigating the effect
of multifocal high-grade dysplasia on recurrence. In
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this study, we present three such cases to increase phy-
sician awareness regarding the possibility of recurrence
and the need for surveillance.
Case 1
A 68-year-old woman had a laparoscopic distal pancre-
atectomy for multifocal IPMN-mixed type with two foci
of high-grade dysplasia detected on ﬁnal pathology anal-
ysis (Fig. 1). Surgical margins were negative. The pa-
tient’s remnant pancreas continued to be monitored
semiannually through cross-sectional studies and inter-
mittent endoscopic ultrasound (EUS) and ﬁne-needle
aspiration (FNA). Eight years from the date of the ﬁrst
surgery, the patient was still symptomatic with intermit-
tent twinges of discomfort in her left upper abdominal
quadrant. Although her physical examination was
unremarkable, her work-up did reveal an elevation in
CA19-9 level from 35 to 44l/mL. Magnetic resonance
cholangiopancreatography (MRCP) disclosed a newly
developed internal enhancement of a 14mm branch
duct cystic dilation adjacent to the distal end (Fig. 2).
Upper endoscopy with esophagogastroduodenoscopy/
FNA of the pancreatic cyst yielded cells consistent with
high-grade atypia. She underwent surgical resection of
the neck/body of the pancreas, and surgical pathology
analysis revealed an invasive well-differentiated adeno-
carcinoma (stage 1B) ofmixed-type IPMNwith evidence
of chronic pancreatitis. The patient completed 6 months
of gemcitabine adjuvant chemotherapy and is still alive 4
years from the time of the second surgery. She was of-
fered completion pancreatectomy but deferred.
Case 2
A 49-year-old woman presented with moderately se-
vere pancreatitis. She required three hospitalizations.
This was traumatic in etiology as she was kicked by a
horse. The patient experienced multiple complications
including thromboembolic events and a pancreatico-
pleural ﬁstula. Owing to escalation of symptoms and
failure to thrive, she presented to medical attention,
and a distal pancreatectomy was pursued. Surgical pa-
thology analysis revealed multifocal high-grade dyspla-
sia PanIN-3, with evidence of chronic pancreatitis in
the specimen (Fig. 3). Three foci of high-grade dyspla-
sia were observed; surgical margins were negative.
Based on remembering Case 1, a multidisciplinary
team was assembled, which included consultation
with a world-renowned pancreatic pathologist. Com-
pletion pancreatectomy was offered, but the consultant
and team’s recommendations were close surveillance.
Semiannual surveillance ensued. Unbeknownst to her
physicians, the patient developed symptoms of pancre-
atitis within 6 months of her initial surgery but the pa-
tient did not complain or present to medical attention.
The patient attributed her symptoms (i.e., back pain) to
her occupation. Two years from the time of surgery, a
FIG. 1. H&E ·100 specimen of pancreatic tail
displaying multifocal high-grade intraductal
papillary mucinous neoplasia. H&E, hematoxylin
and eosin.
FIG. 2. Magnetic resonance cholangio-
pancreatography demonstrating a new
development of enhancement of a branch duct
cystic lesion most distally.
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surveillance computed tomography (CT) scan dis-
closed a newly developed low-density lesion in the
head of the pancreas measuring *1 cm as well as an
isolated liver metastasis; the two lesions were proven
to be adenocarcinoma on biopsy.
Case 3
A 55-year-old woman was referred to our clinic for fur-
ther management after having had a Whipple proce-
dure elsewhere for chronic pancreatitis. The specimen
demonstrated multifocal PanIN-3 with evidence of
chronic pancreatitis in the background. Four foci of
high-grade dysplasia were observed; surgical margins
were negative. The patient was symptomatic with inter-
mittent epigastric pain radiating to the back, which was
thought to be related to pancreatitis. The pain was se-
vere enough to affect her daily activities, resulting in a
chronic narcotic-dependent status and hospitalizations
for pain control. Recent outside CT imaging conﬁrmed
changes compatible with chronic pancreatitis in the
remnant pancreas, as well as the presence of a retained
pancreatic stent thought to be partially contributing to
her pain. Her family history is signiﬁcant for pancreatic
cancer, her sister developing it in her 60s. Owing to her
symptomatology, the retained stent, signiﬁcant family
history, the initial surgical pathology report, and
our experience with the mentioned two cases, comple-
tion pancreatectomy was recommended and pursued.
Final pathology report disclosed the presence of multi-
focal PanIN-3 in the setting of pancreatitis.
Discussion
The presence of multifocal high-grade dysplastic le-
sions raises intriguing questions about pancreatic tu-
morigenesis. Two possible scenarios may explain the
simultaneous occurrence of multiple lesions. First, all
the lesions may share a similar genetic or molecular
background leading to malignant progression, also
known as the ﬁeld theory; or second, these lesions
may arise independently and not share a common tu-
morigenic pathway or event. In a recently published
study aimed at establishing a relationship between histo-
logical subtypes of IPMN and frequencies of speciﬁc ge-
netic mutations,3 Tan et al. examined the mutation
status of adjacent areas within the same patient’s inva-
sive IPMN specimen. For 28% of the cases, they detected
different mutations of the same gene in adjacent areas of
varying dysplastic grade from the same patient; more-
over, they reported the absence of mutations in speci-
mens of higher levels of dysplasia that were present in
specimens of lesser dysplasia from the same patient.
These ﬁndings support a multifocal nature of the tumor-
igenic process within the pancreas. The authors propose
that a ﬁeld defect exists in which the entire pancreas may
be prone to the accumulation of distinct genetic muta-
tions and errors that may eventually evolve into cancer.
In addition, the presence of chronic pancreatitis in
two of our cases highlights the effect that pancreatitis
may have on the outcome. In one cohort study, patients
with chronic pancreatitis were found to have an in-
creased risk of pancreatic cancer.4 Speciﬁcally, 1552
subjects were followed up for a minimum of 2 years,
and of these, 29 (21 male and 8 female subjects) had ev-
idence of cancer of the pancreas 2 or more years after
the diagnosis of pancreatitis during a mean follow-up
(–standard deviation) of 7.4– 5.6 years. In another
case–control study, the relative risk in patients with
chronic pancreatitis was found to be as high as 13.3
compared with the control group.5
The presence and extent of invasive IPMN have con-
sistently been identiﬁed as risk factors for poor out-
comes.2,6 However, risk factors for local recurrence of
noninvasive lesions are not well deﬁned. Furthermore,
the risk of recurrence of multifocal high-grade dysplasia
has not been studied extensively. Prior study evaluating
the association between unifocal high-grade dysplasia
and recurrence has shown that the degree of dysplasia
seen on the specimen is a risk factor.2 The rates of recur-
rence signiﬁcantly increased as the grade of dysplasia in-
creases. After a median of 44.4 months of follow-up, 39
out of 366 (10.7%) patients experienced disease
FIG. 3. H&E ·100 specimen of pancreatic tail
displaying multifocal high-grade dysplasia
pancreatic intraepithelial neoplasia-3.
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recurrence with a median of 18.8 months, and of these
16 (41%) patients did not initially have an invasive
IPMN. Analysis of these recurrences shows that six pa-
tients with high-grade dysplasia developed recurrence—
one of them had an adenocarcinoma, two had recurrent
IPMN, and three had distant metastasis. Therefore,
thorough postoperative surveillance is needed not only
for invasive IPMN but also for benign noninvasive le-
sions and especially those with high-grade dysplasia.
At the Indiana University Pancreatic Cyst and Cancer
Early Detection Center, high-risk patients (i.e., Cases 1
and 2) undergo surveillance that includes annual EUS-
FNA as well as semiannual magnetic resonance imaging
(MRI)-MRCP. Unfortunately, the surveillance strategy
failed for Case 2, prompting a more aggressive approach
in managing Case 3, potentially preventing malignant
recurrence. Therefore, based upon our experience, we
recommend that total pancreatectomy be strongly con-
sidered in ﬁt patients with multifocal high-grade lesions,
whether or not pancreatitis is present. However, pancre-
atic surgery is high risk and has a morbidity rate of 45–
55% and a mortality rate of 2–4%.7,8 Complications after
total pancreatectomy may include brittle diabetes, a very
challenging form of diabetes that is resistant to insulin
treatment, thought to originate from a lack of glucagon
secretion as a result of the surgery. The patient may
also develop pancreatic exocrine insufﬁciency with its as-
sociated fat-soluble vitamin deﬁciency as well as malnu-
trition, typically addressed by adding supplemental
pancreatic enzymes.
Conclusion
Although the surveillance protocol for a resected inva-
sive IPMN is well established, the follow-up for a non-
invasive cystic lesion depends on many factors and is
still a subject of controversy. The rates of recurrence
for unifocal noninvasive IPMN are reported to be
*20%.1 Therefore, the guidelines recommend indeﬁ-
nite close surveillance after achieving clear surgical
margins. However, the risk of progression from multi-
focal high-grade PanIN or IPMN into invasive cancer
is unclear, and no clear recommendations for the man-
agement of these patients exist to date. Based upon our
experience, we are recommending strong consideration
of completion pancreatectomy in ﬁt patients. In the
event, completion pancreatectomy is not pursued, we
would recommend quarterly surveillance with serum
markers, MRI-MRCP, and semiannual EUS-FNA.
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